Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma

Oncology Reports

Volumn 36, Issue 4, 2016, Pages 1861-1867

  Ren, Shuling ^a,b   Li, Guo ^a,b   Liu, Chao ^a,b   Cai, Tao ^a,b,c   Su, Zongwu ^a,b   Wei, Ming ^a,b   She, Li ^a,b   Tian, Yong Quan ^a,b   Qiu, Yuan Zheng ^a,b   Zhang, Xin ^a,b   Liu, Yong ^a,b   Wang, Yunyun ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Otolaryngology Major Disease Research Key Laboratory of Hunan Province   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Deep sequencing; LncRNA n375709; Long non coding RNA; Nasopharyngeal carcinoma; Paclitaxel resistance

Indexed keywords

LONG UNTRANSLATED RNA; PACLITAXEL; ANTINEOPLASTIC AGENT; LONG NON CODING RNA N375709, HUMAN;

ARTICLE; CANCER RESISTANCE; CARCINOMA CELL LINE; CHEMOSENSITIVITY; CNE 2 CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE CONSTRUCT; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; NASOPHARYNX CARCINOMA; NEXT GENERATION SEQUENCING; NPC 5 8F CELL; NPC 6 10B CELL; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; DRUG RESISTANCE; GENETIC TRANSFECTION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; NASOPHARYNX TUMOR; POLYMERASE CHAIN REACTION; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NASOPHARYNGEAL NEOPLASMS; PACLITAXEL; POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; TRANSFECTION;

EID: 84984984858     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4981     Document Type: Article

References (37)

1. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12:421-429, 2002.
2. Chan AT, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF and Felip E; EHNS-ESMO-ESTRO Guidelines Working Group: Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7): vii83-vii85, 2012.
3. Yusuf RZ, Duan Z, Lamendola DE, Penson RT and Seiden MV: Paclitaxel resistance: Molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets 3:1-19, 2003.
4. Tao WY, Liang XS, Liu Y, Wang CY and Pang D: Decrease of let-7f in low-dose metronomic paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer. Int J Biol Sci 11:48-58, 2015.
5. Choi JH, Sheu JJ, Guan B, Jinawath N, Markowski P, Wang TL and Shih IeM: Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res 69:1407-1415, 2009.
6. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25:1915-1927, 2011.
7. Ørom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al: Long noncoding RNAs with enhancer-like function in human cells. Cell 143:46-58, 2010.
8. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, Feil R and Fraser P: The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322:1717-1720, 2008.
9. Harries LW: Long non-coding RNAs and human disease. Biochem Soc Trans 40:902-906, 2012.
10. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71:6320-6326, 2011.
11. Sun M, Gadad SS, Kim DS and Kraus WL: Discovery, annotation, and functional analysis of long noncoding RNAs controlling cell-cycle gene expression and proliferation in breast cancer cells. Mol Cell 59:698-711, 2015.
12. Jin C, Yan B, Lu Q, Lin Y and Ma L: The role of MALAT1/MIR-1/slug axis on radioresistance in nasopharyngeal carcinoma. Tumour Biol 37:4025-4033, 2016.
13. Jiao F, Hu H, Han T, Yuan C, Wang L, Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci 16:6677-6693, 2015.
14. Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F and Liu Y: Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281:1750-1758, 2014.
15. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, De W, Wang Z and Wang R: The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21WAF1/CIP1 expression. PLoS One 8:e77293, 2013.
16. Van Der Burg ME, Vergote I, Onstenk W, Boere IA, Leunen K, Van Montfort CA and Van Doorn HC: Long-term results of weekly paclitaxel carboplatin induction therapy: An effective and well-tolerated treatment in patients with platinum-resistant ovarian cancer. Eur J Cancer 49:1254-1263, 2013.
17. Yoshida K, Sanada M and Ogawa S: Deep sequencing in cancer research. Jpn J Clin Oncol 43:110-115, 2013.
18. Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y and Qiu Y: MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur J Cancer 49:2596-2607, 2013.
19. Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S, Deng T, Huang D, Tian Y and Qiu Y: MIR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro. Cancer Sci 105:1560-1568, 2014.
20. Kong L, Zhang Y, Ye ZQ, Liu XQ, Zhao SQ, Wei L and Gao G: CPC: Assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res 35:W345-W349, 2007.
21. Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y and Liu Y: Genomewide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing. PLoS One 8:e84486, 2013.
22. Moulder S, Helgason T, Janku F, Wheler J, Moroney J, Booser D, Albarracin C, Morrow PK, Atkins J, Koenig K, et al: Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. Ann Oncol 26:1346-1352, 2015.
23. Cai J, Chen S, Zhang W, Zheng X, Hu S, Pang C, Lu J, Xing J and Dong Y: Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway. Phytomedicine 21:1725-1732, 2014.
24. Zhang YY, Xie KM, Yang GQ, Mu HJ, Yin Y, Zhang B and Xie P: The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Int J Hematol 93:361-367, 2011.
25. Li W, Tan GL, Ma YH, Peng XW and He GX: Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45:1035-1040, 2010 (In Chinese).
26. Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5:e1506, 2014.
27. Fiedler J, Breckwoldt K, Remmele CW, Hartmann D, Dittrich M, Pfanne A, Just A, Xiao K, Kunz M, Müller T, et al: Development of long noncoding RNA-based strategies to modulate tissue vascularization. J Am Coll Cardiol 66:2005-2015, 2015.
28. Zhou X and Xu J: Identification of Alzheimer's disease-associated long noncoding RNAs. Neurobiol Aging 36:2925-2931, 2015.
29. Neguembor MV, Jothi M and Gabellini D: Long noncoding RNAs, emerging players in muscle differentiation and disease. Skelet Muscle 4:8, 2014.
30. Xue X, Yang YA, Zhang A, Fong KW, Kim J, Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene: Sep. 14, 2015 (Epub ahead of print). doi: 10.1038/onc.2015.340.
31. Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai Z L, Ishii N and Dahiya R: Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with MIR-205. Cancer Res 75:1322-1331, 2015.
32. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al: The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73:1180-1189, 2013.
33. Zhang W, Wang L, Zheng F, Zou R, Xie C, Guo Q, Hu Q, Chen J, Yang X, Yao H, et al: Long noncoding RNA expression signatures of metastatic nasopharyngeal carcinoma and their prognostic value. Biomed Res Int 2015:618924, 2015.
34. Gao W, Chan JY and Wong TS: Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma. Biomed Res Int 2014:404567, 2014.
35. Zhou Z, Liu H, Wang C, Lu Q, Huang Q, Zheng C and Lei Y: Long non-coding RNAs as novel expression signatures modulate DNA damage and repair in cadmium toxicology. Sci Rep 5:15293, 2015.
36. Cheng Z, Guo J, Chen L, Luo N, Yang W and Qu X: A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer. Oncotarget 6:25381-25389, 2015.
37. Li CH and Chen Y: Targeting long non-coding RNAs in cancers: Progress and prospects. Int J Biochem Cell Biol 45:1895-1910, 2013.